185 related articles for article (PubMed ID: 37467060)
21. Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.
Wang X; Wong K; Ouyang W; Rutz S
Cold Spring Harb Perspect Biol; 2019 Feb; 11(2):. PubMed ID: 29038121
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptors regulate B cell cytokine production in patients with diabetes.
Jagannathan M; McDonnell M; Liang Y; Hasturk H; Hetzel J; Rubin D; Kantarci A; Van Dyke TE; Ganley-Leal LM; Nikolajczyk BS
Diabetologia; 2010 Jul; 53(7):1461-71. PubMed ID: 20383694
[TBL] [Abstract][Full Text] [Related]
23. Immunoreceptor Engineering and Synthetic Cytokine Signaling for Therapeutics.
Scheller J; Engelowski E; Moll JM; Floss DM
Trends Immunol; 2019 Mar; 40(3):258-272. PubMed ID: 30738638
[TBL] [Abstract][Full Text] [Related]
24. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus.
Tsiavou A; Hatziagelaki E; Chaidaroglou A; Manginas A; Koniavitou K; Degiannis D; Raptis SA
J Clin Immunol; 2004 Nov; 24(6):591-9. PubMed ID: 15622443
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 and diabetes: the good, the bad, or the indifferent?
Kristiansen OP; Mandrup-Poulsen T
Diabetes; 2005 Dec; 54 Suppl 2():S114-24. PubMed ID: 16306329
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 controls recycling and degradation, but not internalization of its receptors.
Flynn CM; Kespohl B; Daunke T; Garbers Y; Düsterhöft S; Rose-John S; Haybaeck J; Lokau J; Aparicio-Siegmund S; Garbers C
J Biol Chem; 2021; 296():100434. PubMed ID: 33610555
[TBL] [Abstract][Full Text] [Related]
27. Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant.
Metcalfe RD; Hanssen E; Fung KY; Aizel K; Kosasih CC; Zlatic CO; Doughty L; Morton CJ; Leis AP; Parker MW; Gooley PR; Putoczki TL; Griffin MDW
Nat Commun; 2023 Nov; 14(1):7543. PubMed ID: 37985757
[TBL] [Abstract][Full Text] [Related]
28. Targeting IL-6 trans-signalling: past, present and future prospects.
Rose-John S; Jenkins BJ; Garbers C; Moll JM; Scheller J
Nat Rev Immunol; 2023 Oct; 23(10):666-681. PubMed ID: 37069261
[TBL] [Abstract][Full Text] [Related]
29. Local and systemic effects of interleukin-6 (IL-6) in inflammation and cancer.
Rose-John S
FEBS Lett; 2022 Mar; 596(5):557-566. PubMed ID: 34738234
[TBL] [Abstract][Full Text] [Related]
30. IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes.
Skuratovskaia D; Komar A; Vulf M; Quang HV; Shunkin E; Volkova L; Gazatova N; Zatolokin P; Litvinova L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579000
[TBL] [Abstract][Full Text] [Related]
31. Split
Moll JM; Wehmöller M; Frank NC; Homey L; Baran P; Garbers C; Lamertz L; Axelrod JH; Galun E; Mootz HD; Scheller J
ACS Synth Biol; 2017 Dec; 6(12):2260-2272. PubMed ID: 29136368
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
[TBL] [Abstract][Full Text] [Related]
33. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 Family of Cytokines in Cancers.
Zaporowska-Stachowiak I; Springer M; Stachowiak K; Oduah M; Sopata M; Wieczorowska-Tobis K; Bryl W
J Interferon Cytokine Res; 2024 Feb; 44(2):45-59. PubMed ID: 38232478
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells.
Lindkvist M; Zegeye MM; Grenegård M; Ljungberg LU
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163371
[TBL] [Abstract][Full Text] [Related]
36. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
[TBL] [Abstract][Full Text] [Related]
37. Cytokine Levels in the
Olender A; Bogut A; Magryś A; Tabarkiewicz J
Pol J Microbiol; 2019 Dec; 68(4):457-464. PubMed ID: 31880890
[TBL] [Abstract][Full Text] [Related]
38. The Role of gp130 Cytokines in Tuberculosis.
Ritter K; Rousseau J; Hölscher C
Cells; 2020 Dec; 9(12):. PubMed ID: 33334075
[TBL] [Abstract][Full Text] [Related]
39. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
Lokau J; Garbers C
Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
[TBL] [Abstract][Full Text] [Related]
40. A designer hyper interleukin 11 (H11) is a biologically active cytokine.
Dams-Kozlowska H; Gryska K; Kwiatkowska-Borowczyk E; Izycki D; Rose-John S; Mackiewicz A
BMC Biotechnol; 2012 Mar; 12():8. PubMed ID: 22433466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
